White Papers/Abstracts

White Papers/Abstracts

  1. Regenafil/Regenaform Testing Summary
  2. Regenafil - In Vivo determination of the optimal amount of DBM in a DBM/carrier composite required to optimize bone formation.
  3. Bostrom MP, Yang X, Kennan M, Sandhu H, Dicarlo E, Lane JM. An Unexpected Outcome During Testing of Commercially Available Demineralized Bone Graft Materials. 15th Annual Meeting of the North American Spine Society; 2000 Oct 25-28; New Orleans, LA.
  4. Fox W, Aufdemorte T, Sandhu H. Comparative Histological and Calcium Content Evaluation of OSTEOFIL®, Grafton and DynaGraft Putty Bone Inductive Materials in the Nude Rat at 28 Days. 15th Annual Meeting of the North American Spine Society; 2000 Oct 25-28; New Orleans, LA.
  5. Glazer P, Spencer U, Alkalay R, Schwardt J. In vivo evaluation of calcium sulfate as a bone graft substitute. 15th Annual Meeting of the North American Spine Society; 2000 Oct 25-28; New Orleans, LA.
  6. Jaw R, Silveira E, Yonchek J, Nataraj C. Comparison of Osteoinductive Properties Between Optefil Paste and DBX. RTI Biologics 2010.
  7. Wang J, et al. Prospective Comparison of Commercially Available Demineralized Bone Matrix for Spinal Fusion. 15th Annual Meeting of the North American Spine Society; 2000 Oct 25-28; New Orleans, LA.    
  8. Wang J, et al. Dose-dependent toxicity of a commercially available demineralized bone matrix material. 15th Annual Meeting of the North American Spine Society; 2000 Oct 25-28; New Orleans, LA.